1. Home
  2. ENTA vs ADV Comparison

ENTA vs ADV Comparison

Compare ENTA & ADV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$13.16

Market Cap

374.6M

Sector

Health Care

ML Signal

HOLD

Logo Advantage Solutions Inc.

ADV

Advantage Solutions Inc.

HOLD

Current Price

$38.02

Market Cap

438.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENTA
ADV
Founded
1995
1987
Country
United States
United States
Employees
N/A
73000
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
374.6M
438.2M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
ENTA
ADV
Price
$13.16
$38.02
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
3
Target Price
$20.40
$45.83
AVG Volume (30 Days)
199.8K
83.7K
Earning Date
05-11-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
29.93
N/A
EPS
N/A
N/A
Revenue
$102,814,000.00
N/A
Revenue This Year
$7.76
$0.63
Revenue Next Year
N/A
$0.45
P/E Ratio
N/A
N/A
Revenue Growth
16.48
N/A
52 Week Low
$5.88
$0.49
52 Week High
$17.15
$46.80

Technical Indicators

Market Signals
Indicator
ENTA
ADV
Relative Strength Index (RSI) 41.92 55.07
Support Level $13.00 $1.00
Resistance Level $13.76 $46.80
Average True Range (ATR) 0.72 3.42
MACD -0.13 -0.53
Stochastic Oscillator 8.71 48.13

Price Performance

Historical Comparison
ENTA
ADV

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

About ADV Advantage Solutions Inc.

Advantage Solutions Inc provides outsourced sales, marketing, merchandising, sampling, and retailer support services to consumer packaged goods manufacturers and retailers across North America. Its services are designed to support distribution, retail execution, shopper engagement, and private brand development across both physical and digital commerce environments. The company serves various clients across grocery, mass, club, retail pharmacy, convenience, and other channels. It operates through three reportable segments: Branded Services, Experiential Services, and Retailer Services. The majority of the revenue is derived from the Experiential Services segment, which provides in-store and digital sampling programs, demonstrations, and experiential events for manufacturers and retailers.

Share on Social Networks: